The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.

2.50
Hdl Handle:
http://hdl.handle.net/11287/600373
Title:
The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
Authors:
Crathorne, L.; Huxley, N.; Haasova, M.; Snowsill, T.; Jones-Hughes, T.; Hoyle, M.; Briscoe, S.; Coelho, H.; Long, L.; Medina-Lara, A.; Mujica-Mota, R.; Napier, Mark; Hyde, C.
Abstract:
Anaemia is a common side effect of cancer treatments and can lead to a reduction in quality of life. Erythropoiesis-stimulating agents (ESAs) are licensed for use in conjunction with red blood cell transfusions to improve cancer treatment-induced anaemia (CIA).
Citation:
The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model. 2016, 20 (13):1-588 Health Technol Assess
Publisher:
Health Technology Assessment
Journal:
Health technology assessment (Winchester, England)
Issue Date:
Feb-2016
URI:
http://hdl.handle.net/11287/600373
DOI:
10.3310/hta20130
PubMed ID:
26907163
Additional Links:
http://www.journalslibrary.nihr.ac.uk/hta/volume-20/issue-13#abstract
Note:
This report is freely available via the NIHR Journals Library. Click on the 'Additional Link' above to access the full-text.
Type:
Journal Article; Systematic review
Language:
en
ISSN:
2046-4924
Appears in Collections:
Oncology; 2016 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorCrathorne, L.en
dc.contributor.authorHuxley, N.en
dc.contributor.authorHaasova, M.en
dc.contributor.authorSnowsill, T.en
dc.contributor.authorJones-Hughes, T.en
dc.contributor.authorHoyle, M.en
dc.contributor.authorBriscoe, S.en
dc.contributor.authorCoelho, H.en
dc.contributor.authorLong, L.en
dc.contributor.authorMedina-Lara, A.en
dc.contributor.authorMujica-Mota, R.en
dc.contributor.authorNapier, Marken
dc.contributor.authorHyde, C.en
dc.date.accessioned2016-02-29T14:15:30Zen
dc.date.available2016-02-29T14:15:30Zen
dc.date.issued2016-02en
dc.identifier.citationThe effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model. 2016, 20 (13):1-588 Health Technol Assessen
dc.identifier.issn2046-4924en
dc.identifier.pmid26907163en
dc.identifier.doi10.3310/hta20130en
dc.identifier.urihttp://hdl.handle.net/11287/600373en
dc.description.abstractAnaemia is a common side effect of cancer treatments and can lead to a reduction in quality of life. Erythropoiesis-stimulating agents (ESAs) are licensed for use in conjunction with red blood cell transfusions to improve cancer treatment-induced anaemia (CIA).en
dc.language.isoenen
dc.publisherHealth Technology Assessmenten
dc.relation.urlhttp://www.journalslibrary.nihr.ac.uk/hta/volume-20/issue-13#abstracten
dc.rightsArchived with thanks to Health Technology Assessment (Winchester, England)en
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.en
dc.titleThe effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.en
dc.typeJournal Articleen
dc.typeSystematic reviewen
dc.identifier.journalHealth technology assessment (Winchester, England)en
dc.description.noteThis report is freely available via the NIHR Journals Library. Click on the 'Additional Link' above to access the full-text.en
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.